The CRISPR ancillary effector Can2 is a dual-specificity nuclease potentiating type III CRISPR defence. (2021)
Attributed to:
Cyclic oligoadenylate signalling - a new type of antiviral response
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/nar/gkab073
PubMed Identifier: 33590098
Publication URI: http://europepmc.org/abstract/MED/33590098
Type: Journal Article/Review
Volume: 49
Parent Publication: Nucleic acids research
Issue: 5
ISSN: 0305-1048